{"id":829313,"date":"2025-03-25T07:33:05","date_gmt":"2025-03-25T11:33:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\/"},"modified":"2025-03-25T07:33:05","modified_gmt":"2025-03-25T11:33:05","slug":"redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\/","title":{"rendered":"Redwire Awarded NASA Contract to Expand Pharmaceutical Drug Development in Space for Future Commercialization"},"content":{"rendered":"<p>        <!--body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>Redwire Awarded NASA Contract to Expand Pharmaceutical Drug Development in Space for Future Commercialization<\/b><\/p>\n<p>JACKSONVILLE, Fla.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nRedwire Corporation (NYSE: RDW), a leader in space infrastructure for the next-generation space economy, has been awarded a NASA contract to launch four additional pharmaceutical drug investigations to the International Space Station using the company\u2019s innovative Pharmaceutical In-space Laboratory (PIL-BOX). The NASA-funded investigations aim to manufacture high-value seed crystals which could inform pharmaceutical manufacturing operations aboard the space station and future commercial space stations in low Earth orbit (LEO).\n<\/p>\n<p>\n\u201cNASA has been an instrumental partner and customer as we\u2019ve scaled our pharmaceutical drug manufacturing program significantly over the last year,\u201d said John Vellinger, Redwire\u2019s President of In-Space Industries. \u201cAdditional PIL-BOX investigations from NASA and commercial partners will enable Redwire to optimize the infrastructure to launch, test, manufacture, and return high-value space enabled pharmaceutical products and establish a new market in LEO\u201d\n<\/p>\n<p>\nWith 28 units flown and processed to date, PIL-BOX provides pharmaceutical researchers with novel and flexible services to leverage the microgravity environment to grow small-batch crystals of protein-based pharmaceuticals and other key pharmaceutically relevant molecules. Previous spaceflight investigations indicate that growing crystals in space could yield a more uniform product with fewer imperfections, which can improve the drug discovery and development process. Previous investigations have focused on unlocking insights to improve treatments for cardiovascular disease, obesity, and diabetes.\n<\/p>\n<p><b>About Redwire<\/b><\/p>\n<p>\nRedwire Corporation (NYSE: RDW) is a global space infrastructure and innovation company enabling civil, commercial, and national security programs. Redwire\u2019s proven and reliable capabilities include avionics, sensors, power solutions, critical structures, mechanisms, radio frequency systems, platforms, missions, and microgravity payloads. Redwire combines decades of flight heritage and proven experience with an agile and innovative culture. Redwire\u2019s approximately 750 employees working from 17 facilities located throughout the United States and Europe are committed to building a bold future in space for humanity, pushing the envelope of discovery and science while creating a better world on Earth. For more information, please visit redwirespace.com.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250325785635r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250325785635\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250325785635\/en\/<\/a><\/span><\/p>\n<p><b>Media Contact:<br \/>\n<\/b><br \/>Tere Riley<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:tere.riley@redwirespace.com\">tere.riley@redwirespace.com<br \/>\n<\/a><br \/>321-831-0134<\/p>\n<p>OR<\/p>\n<p><b>Investors:<br \/>\n<\/b><br \/><a rel=\"nofollow\" href=\"mailto:investorrelations@redwirespace.com\">investorrelations@redwirespace.com<br \/>\n<\/a><br \/>904-425-1431\n<\/p>\n<p><b>KEYWORDS:<\/b> United States North America Florida<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Aerospace Technology Manufacturing Diabetes Health Pharmaceutical Other Technology Satellite Research Other Manufacturing Science<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250325785635\/en\/1852945\/3\/redwire-logo-wbg-2.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Redwire Awarded NASA Contract to Expand Pharmaceutical Drug Development in Space for Future Commercialization JACKSONVILLE, Fla.&#8211;(BUSINESS WIRE)&#8211; Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next-generation space economy, has been awarded a NASA contract to launch four additional pharmaceutical drug investigations to the International Space Station using the company\u2019s innovative Pharmaceutical In-space Laboratory (PIL-BOX). The NASA-funded investigations aim to manufacture high-value seed crystals which could inform pharmaceutical manufacturing operations aboard the space station and future commercial space stations in low Earth orbit (LEO). \u201cNASA has been an instrumental partner and customer as we\u2019ve scaled our pharmaceutical drug manufacturing program significantly over the last year,\u201d said John Vellinger, Redwire\u2019s President of In-Space Industries. \u201cAdditional PIL-BOX investigations from NASA &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Redwire Awarded NASA Contract to Expand Pharmaceutical Drug Development in Space for Future Commercialization&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-829313","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Redwire Awarded NASA Contract to Expand Pharmaceutical Drug Development in Space for Future Commercialization - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Redwire Awarded NASA Contract to Expand Pharmaceutical Drug Development in Space for Future Commercialization - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Redwire Awarded NASA Contract to Expand Pharmaceutical Drug Development in Space for Future Commercialization JACKSONVILLE, Fla.&#8211;(BUSINESS WIRE)&#8211; Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next-generation space economy, has been awarded a NASA contract to launch four additional pharmaceutical drug investigations to the International Space Station using the company\u2019s innovative Pharmaceutical In-space Laboratory (PIL-BOX). The NASA-funded investigations aim to manufacture high-value seed crystals which could inform pharmaceutical manufacturing operations aboard the space station and future commercial space stations in low Earth orbit (LEO). \u201cNASA has been an instrumental partner and customer as we\u2019ve scaled our pharmaceutical drug manufacturing program significantly over the last year,\u201d said John Vellinger, Redwire\u2019s President of In-Space Industries. \u201cAdditional PIL-BOX investigations from NASA &hellip; Continue reading &quot;Redwire Awarded NASA Contract to Expand Pharmaceutical Drug Development in Space for Future Commercialization&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-25T11:33:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250325785635r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Redwire Awarded NASA Contract to Expand Pharmaceutical Drug Development in Space for Future Commercialization\",\"datePublished\":\"2025-03-25T11:33:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\\\/\"},\"wordCount\":402,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250325785635r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\\\/\",\"name\":\"Redwire Awarded NASA Contract to Expand Pharmaceutical Drug Development in Space for Future Commercialization - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250325785635r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2025-03-25T11:33:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250325785635r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250325785635r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Redwire Awarded NASA Contract to Expand Pharmaceutical Drug Development in Space for Future Commercialization\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Redwire Awarded NASA Contract to Expand Pharmaceutical Drug Development in Space for Future Commercialization - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\/","og_locale":"en_US","og_type":"article","og_title":"Redwire Awarded NASA Contract to Expand Pharmaceutical Drug Development in Space for Future Commercialization - Market Newsdesk","og_description":"Redwire Awarded NASA Contract to Expand Pharmaceutical Drug Development in Space for Future Commercialization JACKSONVILLE, Fla.&#8211;(BUSINESS WIRE)&#8211; Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next-generation space economy, has been awarded a NASA contract to launch four additional pharmaceutical drug investigations to the International Space Station using the company\u2019s innovative Pharmaceutical In-space Laboratory (PIL-BOX). The NASA-funded investigations aim to manufacture high-value seed crystals which could inform pharmaceutical manufacturing operations aboard the space station and future commercial space stations in low Earth orbit (LEO). \u201cNASA has been an instrumental partner and customer as we\u2019ve scaled our pharmaceutical drug manufacturing program significantly over the last year,\u201d said John Vellinger, Redwire\u2019s President of In-Space Industries. \u201cAdditional PIL-BOX investigations from NASA &hellip; Continue reading \"Redwire Awarded NASA Contract to Expand Pharmaceutical Drug Development in Space for Future Commercialization\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-25T11:33:05+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250325785635r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Redwire Awarded NASA Contract to Expand Pharmaceutical Drug Development in Space for Future Commercialization","datePublished":"2025-03-25T11:33:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\/"},"wordCount":402,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250325785635r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\/","name":"Redwire Awarded NASA Contract to Expand Pharmaceutical Drug Development in Space for Future Commercialization - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250325785635r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2025-03-25T11:33:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250325785635r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250325785635r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/redwire-awarded-nasa-contract-to-expand-pharmaceutical-drug-development-in-space-for-future-commercialization\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Redwire Awarded NASA Contract to Expand Pharmaceutical Drug Development in Space for Future Commercialization"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/829313","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=829313"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/829313\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=829313"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=829313"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=829313"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}